The store will not work correctly when cookies are disabled.
3-[[1,3-Benzodioxol-5-ylmethyl-[2-(hydroxy-amino)-2-oxo-ethyl]-amino]-methyl]benzoic Acid
ID: ALA4215019
Chembl Id: CHEMBL4215019
PubChem CID: 132051441
Max Phase: Preclinical
Molecular Formula: C18H18N2O6
Molecular Weight: 358.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN(Cc1cccc(C(=O)O)c1)Cc1ccc2c(c1)OCO2)NO
Standard InChI: InChI=1S/C18H18N2O6/c21-17(19-24)10-20(8-12-2-1-3-14(6-12)18(22)23)9-13-4-5-15-16(7-13)26-11-25-15/h1-7,24H,8-11H2,(H,19,21)(H,22,23)
Standard InChI Key: KXEKYVROYPRQEX-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.35 | Molecular Weight (Monoisotopic): 358.1165 | AlogP: 1.62 | #Rotatable Bonds: 7 |
Polar Surface Area: 108.33 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.65 | CX Basic pKa: 6.07 | CX LogP: -0.43 | CX LogD: -1.54 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.51 | Np Likeness Score: -0.71 |
References
1. Ramsbeck D, Hamann A, Richter G, Schlenzig D, Geissler S, Nykiel V, Cynis H, Schilling S, Buchholz M.. (2018) Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors., 61 (10): [PMID:29694039] [10.1021/acs.jmedchem.8b00330] |